The Business Research Company's Global Albumin Market Size, Share And Growth Analysis For 2024-2033
LONDON, GREATER LONDON, UK, August 15, 2024 /EINPresswire.com/ -- The albumin market has experienced robust growth in recent years, expanding from $6.03 billion in 2023 to $6.57 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to advancements in biotechnology, increased demand for plasma-derived therapies, expanding applications in pharmaceuticals, high prevalence of liver diseases, regulatory approvals for albumin-based products, and globalization of healthcare leading to wider market access.
Strong Future Growth Anticipated
The albumin market is projected to continue its strong growth, reaching $9.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the increasing prevalence of liver diseases, expanding applications in regenerative medicine, rising geriatric population, evolving diagnostic techniques, shifting healthcare infrastructure towards outpatient care, and growing awareness about the importance of maintaining optimal protein levels.
Explore Comprehensive Insights Into The Global Albumin Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16333&type=smp
Growth Driver Of The Albumin Market
The rising incidence of diabetes is expected to propel the growth of albumin market going forward. Diabetes is a metabolic disease characterized by high blood sugar levels over a prolonged period. The number of diabetes cases is rising because of poor nutrition, a lack of physical activity, hormonal conditions, and obesity. Albumin is an important biomarker in diabetes that can guide insulin therapy, monitor glycemic control, aid in diagnosis, and predict complications such as diabetic ketoacidosis (DKA). Maintaining normal albumin levels is crucial for the overall management of diabetes.
Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/albumin-global-market-report
Major Players And Market Trends
Key players in the albumin market include Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited.
Major companies operating in the albumin market are developing innovative products, such as an animal- and human-origin-free recombinant albumin, to better serve customers with advanced features. An animal- and human-origin-free recombinant albumin refers to a type of albumin that is manufactured using a non-mammalian expression system, such as yeast, and does not contain any components derived from animals or humans.
Segments:
1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin
2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications
3) By Sales Channel: Business-To-Consumer (B2C), Business-To-Business (B2B)
4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes
Geographical Insights: North America Leading The Market
North America was the largest region in the albumin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Albumin Market Definition
Albumin is a type of protein found in blood plasma, serum, muscle, the whites of eggs, milk, and other animal substances, as well as in many plant tissues and fluids. It is a simple, heat-coagulable, and water-soluble protein that plays a crucial role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.
Albumin Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Albumin Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on albumin market size, albumin market drivers and trends, albumin market major players, albumin competitors' revenues, albumin market positioning, and albumin market growth across geographies. The albumin market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Stem Cell Assay Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Glycomics or Glycobiology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report
Hospital Capacity Management Solutions Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hospital-capacity-management-solutions-global-market-report
About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
